This animation has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in PracticeBoehringer Ingelheim Ltd suggested the topic and the presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The sponsorship fee included an honorarium for the presenter. The views and opinions expressed in the animation are not necessarily those of Boehringer Ingelheim Ltd, or of Guidelines in Practice, its publisher, advisers, or advertisers. No part of this animation may be reproduced in any form without the permission of the publisher.

View Spiolto Respimat (tiotropium and olodaterol) prescribing information.

View Spiriva Respimat (tiotropium) prescribing information.

The reusable Respimat® Soft Mist™ inhaler is a handheld propellant-free device that produces a slow-moving, long-lasting mist of drug for inhalation. The original Respimat inhaler has been available since 2007, but in September 2019 it became available in the UK as a reusable device.

Dr Richard Russell (Consultant Chest Physician at Southern Health NHSFT) presents this short animation covering:

  • the updated features of the reusable Respimat inhaler
  • clinical data on usability and performance
  • environmental impact of switching from disposable to reusable inhalers.

PC-UK-102088 V2

Date of preparation: March 2020